EPLBD With Limited EST vs. EPLBD for Choledocholithiasis

NCT05056506 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2023-08-16

No results posted yet for this study

Summary

Endoscopic papillary balloon dilation (EPBD) for choledocholithiasis is known to be comparable to endoscopic sphincterotomy (EST) especially in cases of small stones. With larger stones (\> 10 mm), EPBD with conventional balloon, which have a diameter of 6-8 mm, was reported as less effective for extraction of stones, requiring additional mechanical lithotripsy (ML). The present study aims to compare the efficacy and safety of limited EST plus endoscopic papillary balloon dilation (EST-EPBD) with endoscopic papillary large balloon dilation for large choledocholithiasis.

Conditions

  • Choledocholithiasis

Interventions

PROCEDURE

EPLBD

Endoscopic papillary large balloon dilation for Choledocholithiasis

PROCEDURE

ELPBD+ESD

Endoscopic papillary balloon dilation combined with limited endoscopic sphincterotomy for Choledocholithiasis

Sponsors & Collaborators

  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER
  • Second Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • The Second Affiliated Hospital of Jiaxing University

    collaborator OTHER
  • Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

    collaborator OTHER
  • Shanghai Fourth People's Hospital Tongji University

    collaborator OTHER
  • Jianfeng Yang

    lead OTHER

Principal Investigators

  • Xiaofeng Zhang · Zhejiang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-10-30
Completion
2023-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05056506 on ClinicalTrials.gov